Dupixent (dupilumab) Patient Assistance Program
Don’t let the high cost of brand specialty IL-4/IL-13 biologic therapy disrupt your treatment. We help eligible patients access Dupixent (dupilumab) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.
- Clear & Transparent Pricing
- Paperwork & Doctor-Coordination
- Comprehensive Support: From Application to Entire Journey.
- Annual Re-certification And Refills Management
- Medicare Part D Patients Accepted
HIPAA Compliant
BBB Accredited
Secure Website
Key Takeaways:
- Dupixent (dupilumab) is FDA-approved for moderate-to-severe atopic dermatitis (eczema) in patients ≥6 months, moderate-to-severe asthma with type 2 inflammation in patients ≥6 years, chronic rhinosinusitis with nasal polyps in adults, eosinophilic esophagitis (EoE) in patients ≥1 year and ≥15 kg, prurigo nodularis in adults, chronic obstructive pulmonary disease (COPD) with type 2 inflammation in adults, and chronic spontaneous urticaria in patients ≥12 years. It is a dual IL-4/IL-13 receptor blocker.
- Without assistance, Dupixent costs commonly run approximately $3,500–$4,000 per monthly maintenance (every-2-week SC injection), with annual costs commonly $42,000–$48,000+.
- Through AffordMyPrescriptions, qualifying patients can access Dupixent for a flat $69.95 per month — our advocacy team manages the entire enrollment, refills, and renewal process.
- There is no biosimilar of Dupixent in the U.S. as of 2026. For atopic dermatitis, other systemic options include JAK inhibitors (Rinvoq, Cibinqo) and tralokinumab (Adbry, IL-13). For severe asthma with type 2 inflammation, other biologics include Nucala (IL-5), Fasenra (IL-5R), and Tezspire (anti-TSLP).
What Is Dupixent Prescription Assistance Program?
The Dupixent Prescription Assistance Program is a manufacturer-sponsored initiative that provides Dupixent at little or no medication cost to qualifying patients based on income and insurance status. The program is designed for atopic dermatitis, severe asthma, nasal polyps, EoE, and other approved indications in patients who are uninsured or underinsured, as well as Medicare Part D beneficiaries.
Navigating the program on your own means dealing with eligibility verification, dermatology/allergy/pulmonology/gastroenterology coordination, prior-authorization documentation, specialty pharmacy logistics, and renewal deadlines.
AffordMyPrescriptions eliminates that burden. For a flat $69.95 per month, our Patient Advocates handle every step of your enrollment, from initial application through ongoing refill coordination and annual re-certification.
Pharmacy Price Comparison
- Without assistance, Dupixent costs roughly $3,500–$4,000 per month. A Patient Assistance Program is the meaningful path forward — if you qualify:
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Walgreens | ~$3,900/mo | Save ~$3,830/mo |
| CVS Pharmacy | ~$4,000/mo | Save ~$3,930/mo |
| Walmart | ~$3,600/mo | Save ~$3,530/mo |
| Costco | ~$3,550/mo | Save ~$3,480/mo |
Specialty Pharmacy | ~$3,700/mo | Save ~$3,630/mo |
*Just a heads-up — retail prices are estimates based on public data and vary by pharmacy. AffordMyPrescriptions Advocacy Service bypasses this by using drug manufacturer programs to secure your medication directly at no cost or retail price.
Our Pricing:
$69.95 Per month
1 Medications
$79.95 Per Month
2 Medications
$89.95 Per Month
3 Medications
$99.95 Per Month
4+ Medications
Why choose us For Your Dupixent Prescription Program?
The Patient Assistance Program is free to apply for and provides Dupixent at no medication cost if approved. Our $69.95/month service covers full advocacy.
Enroll
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
We Advocate
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Receive Medication
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Discount Coupons vs. Patient Assistance Programs
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Dupixent:
Limitations of Coupons
- Prices fluctuate — savings aren’t guaranteed month-to-month
- Copay accumulators may prevent savings from counting toward deductible
- Coupon cards expire and require constant renewal
Still $3,500–$4,000/mo per month even with the best discount
- Can’t be used with Medicare, Medicaid, or government insurance
Advantages of PAP Through Us
- Fixed $69.95/month — never changes regardless of retail price
- No expiration — continuous access as long as you qualify
- Medication supplied directly through the assistance program
- We manage all paperwork, refills, and annual renewals
- If denied, we explore alternative savings on your behalf
DO YOU QUALIFY?
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Dupixent assistance.
- You Are A U.S. Citizen Or Legal Resident
- You Have A Valid Dupixent Prescription From A Licensed U.S. Healthcare Provider
- You Are Uninsured, Underinsured, Or A Medicare Part D Beneficiary
- You Have Recently Experienced A Change In Financial Circumstances That Affects Your Ability To Pay
Not sure if you qualify? Our pre-qualification check is completely free. If we can’t help, you won’t be charged.
Understanding Dupixent:
Dupixent (dupilumab) is a fully human monoclonal antibody that blocks signaling of both interleukin-4 (IL-4) and interleukin-13 (IL-13) by binding the shared IL-4Rα receptor subunit. IL-4 and IL-13 are key drivers of type 2 inflammation — central to atopic dermatitis, allergic asthma, nasal polyposis, eosinophilic esophagitis, and other type 2 conditions.
How Dupixent Works:
Dupilumab (Dupixent) blocks the IL-4Rα subunit, a receptor shared by both interleukin-4 (IL-4) and interleukin-13 (IL-13). By inhibiting these two key cytokines, it stops the signaling that drives Type 2 inflammation, which involves Th2 cells, eosinophils, mast cells, and IgE. This dual blockade helps control the underlying biology responsible for conditions like atopic dermatitis, allergic asthma, and nasal polyps. Consequently, it leads to reduced inflammation, improved skin and esophageal symptoms, and fewer asthma flare-ups.
Form and use:
Dupixent is administered at home as a subcutaneous injection using prefilled pens or syringes, requiring no premedication. Dosing depends on the specific medical condition, typically starting with a loading dose followed by maintenance injections every two weeks for adults. For example, adults with atopic dermatitis take a 600 mg loading dose followed by 300 mg every two weeks, while asthma and nasal polyp doses vary. Pediatric dosing is unique because it is calculated based on the child’s weight.
Generic availability:
As of 2026, there is no biosimilar version of Dupixent available in the United States. However, alternative systemic treatments exist, such as oral JAK inhibitors (Rinvoq, Cibinqo) and tralokinumab (Adbry) for atopic dermatitis. For severe asthma with type 2 inflammation, other biologic alternatives include Nucala, Fasenra, Cinqair, Xolair (which has a biosimilar, Omlyclo), and Tezspire. These alternative medications target different components of the inflammatory pathway, such as IL-13, IL-5, IgE, or TSLP.
Warnings:
Dupixent carries risks for hypersensitivity reactions, including rare cases of anaphylaxis, and eye conditions like conjunctivitis and keratitis. Patients may experience eosinophilia, which can sometimes present as vasculitis or conditions resembling eosinophilic granulomatosis with polyangiitis, particularly when lowering oral corticosteroid doses. If any new symptoms suggesting these conditions appear, patients must notify their healthcare provider immediately. Additionally, live vaccines should be avoided while using this medication due to a possible reduction in their efficacy.
FAQ (Frequently Asked Questions)
How Much Does Dupixent Cost Without Insurance?
Dupixent costs approximately $3,500–$4,000 per monthly maintenance (every-2-week SC injection). Annual costs commonly $42,000–$48,000+. Through AffordMyPrescriptions, qualifying patients receive Dupixent at no medication cost — our $69.95 monthly fee covers full advocacy and program management.
How Quickly Will Dupixent Work?
For atopic dermatitis, many patients see improvement in itch within 1–2 weeks and significant skin clearance within 4–8 weeks, with maximum benefit typically at 16 weeks. For asthma, symptom improvement and exacerbation reduction is typically seen within weeks. For nasal polyps, polyp shrinkage and symptom improvement develop over weeks to months. For EoE, esophageal symptom and eosinophil improvement is typically assessed at 24 weeks.
How Is Dupixent Different From JAK Inhibitors For Eczema?
Dupixent is a biologic — a subcutaneous monoclonal antibody given every 2 weeks. It is highly effective for atopic dermatitis with a relatively benign safety profile. JAK inhibitors (Rinvoq/upadacitinib, Cibinqo/abrocitinib) are oral daily pills — often very rapidly effective for itch and skin clearance, but carry JAK-class boxed warnings (infections, cardiovascular events, thrombosis, malignancy, mortality) that Dupixent does not. Choice depends on speed of needed response, route preference, and risk tolerance.
What About Eye Side Effects?
Conjunctivitis (eye redness, irritation) is common with Dupixent in atopic dermatitis (less common in other indications). Most cases are mild and managed with lubricating eye drops or short courses of topical ophthalmic anti-inflammatory drops. Tell your prescriber about persistent eye symptoms.
Are There Drug Interactions I Should Know About?
Dupixent has minimal pharmacokinetic drug interactions because it is an antibody (no CYP450 metabolism). The main concern is live vaccines — avoid live vaccines while on Dupixent. Inactivated vaccines are fine. Tell your prescriber about all medications and supplements.
Can I Get Dupixent Through The PAP If I Have Medicare?
Yes. Medicare Part D beneficiaries can typically qualify, especially if you face specialty-tier copays. The manufacturer’s commercial copay savings program is reserved for commercially insured patients only — but the underlying PAP supports Medicare patients who meet income criteria.
What If My Application Is Denied?
If denied, we explore alternatives — switching to a different biologic for the same indication with its own PAP (Tezspire/Nucala/Fasenra for severe asthma; Adbry/Rinvoq/Cibinqo for atopic dermatitis; Xolair for asthma/CRSwNP/CSU), the manufacturer’s copay program for commercially insured patients, or independent foundations such as the National Eczema Association, American Lung Association, Asthma and Allergy Foundation of America, PAN Foundation, or HealthWell Foundation. If we cannot find a path, you won’t be charged our service fee.
Take Control of Your Medication Costs
If you are struggling with the high cost of Dupixent, our team may be able to help you access assistance programs designed to make brand specialty IL-4/IL-13 biologic therapy affordable. Check your eligibility today.
Submit Enrollment Form
Start free by filling out a simple online form.
Receive Welcome Call
Our specialist will contact you for a quick welcome call.
We Manage The Process
Our team handles everything, so you can focus on your health.